雾化吸入辅助治疗小儿喘息样支气管炎的临床分析

Clinical Analysis of Nebulizer Helper Therapy in Children with Asthmatoid Bronchitis

目的 观察舒喘灵、异丙托溴铵雾化吸入对喘息型支气管炎的疗效。方法 单纯随机抽样法将喘支患儿 110例随机分为三组 :雾化吸入治疗组 ,在对照组治疗基础上给予舒喘灵、异丙托溴铵雾化吸入。对照组用青霉素加克毒清治疗。氨茶碱控释片治疗组 ,在对照组治疗基础上加用氨茶碱控释片口服。结果 治疗 2 4h后雾化吸入组在咳嗽、喘息和治愈率与对照组比较 ,P均 <0 .0 5 ,有显著性差异 ,治疗 2 4h后雾化吸入组在咳嗽、喘息和治愈率与氨茶碱组比较 ,P均 >0 .0 5 ,无显著性差异 ,雾化吸入组在住院天数与对照组及氨茶碱组比较 ,P均 <0 .0 5 ,有显著性差异。结论 在普通病原治疗基础上加用舒喘灵、异丙托溴铵雾化吸入对快速缓解喘息型支气管炎症状、缩短病程和提高治愈率明显优于对照组和氨茶碱组 ,疗效显著 。

Objective To observe the effect of quickly remitting the cough?asthma and dyspnea by nebulizer in children with asthmatoid bronchitis. Methods 110cases of children with asthmatoid bronchitis were randomly divided into three groups: 40 cases in nebulizer group were nebulized salbutamol?ipratropium bromide and 0.9%NS besides of being injected penicillin and keduqing.34 cases in control group were only injected penicillin and keduqing. 36 cases in aminophylline group were given aminophylline and injected penicilline and keduqing. Results The better effect to the children with asthmatoid bronchitis by nebulizing salbutamol? ipratropium bromide and 0.9%NS has been proved.The nebulizer group had an obervious effect compared with the control group(P<0.05),and had no significantly different from the aminophylline group(P>0.05).Compared with the course of the last two groups,the nebulizer group had an obervious different with the aminophylline group(P<0.05). Conclusion It could quickly remit the symptom such as the cough?asthma and dyspnea , shorten the course and increase the cure rate.The effect of nebulizer were significantly better than control group and aminophylline group.